Researchers develop new platinum-based anti-tumor compound

Feb 11, 2009

Researchers in the Department of Chemistry at Wake Forest University in collaboration with colleagues at the Wake Forest University Health Sciences Comprehensive Cancer Center have developed a new class of platinum-based anti-tumor drugs that animal studies have shown to be 10 times more effective than current treatments in destroying certain types of lung cancer cells.

The results were published in the December 11 issue of the Journal of Medicinal Chemistry and highlighted in Science-Business eXchange (SciBX), produced by the publisher of the journal Nature. They suggest a new approach to fighting non-small cell lung cancer, which accounts for more than three-quarters of all lung cancers. Lung cancer is the leading cause of cancer-related deaths in both men and women. Less than a third of non-small cell lung cancer patients respond to traditional platinum-based therapies, and those who do respond have a median survival of less than a year.

"We are able to slow the growth of this cancer substantially in mice," said principal investigator Ulrich Bierbach, Z. Smith Reynolds Foundation Fellow and associate professor of chemistry at Wake Forest. "That is very good news, since this is such a rapidly growing, intractable type of cancer."

The new compound's potency derives from its ability to rapidly bind with and disable a tumor cell's DNA before the cell's natural repair mechanisms are activated. That repair process causes drug resistance, which reduces the effectiveness of currently used platinum-based drugs.

Bierbach has focused his research efforts since 1992 on finding ways to overcome the resistance problems inherent in platinum-based drugs. He joined the Wake Forest faculty in 1999, and since 2001, has led a research team that included participation by eight graduate students and more than 30 undergraduate students. The recent paper marks the 25th he has published on the topic.

"If this ends up in clinical trials in the next few years, that will fulfill a dream of mine," Bierbach said.

His research efforts will now be directed toward finding ways to boost the tumor-killing potency of the new compounds while reducing harmful side effects.

Source: Wake Forest University

Explore further: Synthesis produces new antibiotic: Scientists confirm potent synthesis of natural tetracycline

add to favorites email to friend print save as pdf

Related Stories

Hookah use widespread among college students

Apr 05, 2011

Despite a growing number of cities instituting smoking bans across the country, hookah bars are cropping up everywhere – from chic downtown cafes to locations near college campuses, where they've found a loyal customer ...

Small peptide found to stop lung cancer tumor growth in mice

Aug 26, 2009

In new animal research done by investigators at Wake Forest University School of Medicine, scientists have discovered a treatment effective in mice at blocking the growth and shrinking the size of lung cancer tumors, one ...

Recommended for you

Protein glue shows potential for use with biomaterials

17 hours ago

Researchers at the University of Milan in Italy have shown that a synthetic protein called AGMA1 has the potential to promote the adhesion of brain cells in a laboratory setting. This could prove helpful ...

Breaking benzene

Aug 27, 2014

Aromatic compounds are found widely in natural resources such as petroleum and biomass, and breaking the carbon-carbon bonds in these compounds plays an important role in the production of fuels and valuable ...

User comments : 0